Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic Leukemia

被引:1
|
作者
Jarusiewicz, Jamie A. [1 ]
Yoshimura, Satoshi [2 ]
Actis, Marisa [1 ]
Li, Yong [1 ]
Fu, Xiang [1 ]
Yang, Lei [1 ]
Narina, Shilpa [3 ,4 ]
Pruett-Miller, Shondra M. [3 ,4 ]
Zhou, Suiping [5 ]
Wang, Xusheng [5 ]
High, Anthony A. [5 ]
Nishiguchi, Gisele [1 ]
Yang, Jun J. [2 ]
Rankovic, Zoran [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Pharm & Pharmaceut Sci, Memphis, TN 38105 USA
[3] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Memphis, TN 38105 USA
[4] St Jude Childrens Res Hosp, Ctr Adv Genome Engn, Memphis, TN 38105 USA
[5] St Jude Childrens Res Hosp, Ctr Proteom & Metabol, Memphis, TN 38105 USA
关键词
PROTEIN; ABSORPTION;
D O I
10.1021/acs.jmedchem.4c00481
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Despite significant advances over recent years, the treatment of T cell acute lymphoblastic leukemia (T-ALL) remains challenging. We have recently shown that a subset of T-ALL cases exhibited constitutive activation of the lymphocyte-specific protein tyrosine kinase (LCK) and were consequently responsive to treatments with LCK inhibitors and degraders such as dasatinib and dasatinib-based PROTACs. Here we report the design, synthesis and in vitro/vivo evaluation of SJ45566, a potent and orally bioavailable LCK PROTAC.
引用
收藏
页码:11868 / 11884
页数:17
相关论文
共 50 条
  • [1] Novel Orally Available Degrader to Target Lck in T-Cell Acute Lymphoblastic Leukemia
    Jeong, Na-Rae
    Lim, Ye Seul
    Yoo, Sun-Mi
    Kim, Han Wool
    Kim, So Hyuk
    Choi, Ae-Ran
    Kim, Dong-Wook
    Lee, Song Hee
    BLOOD, 2023, 142
  • [2] Development of Proteolytic Targeting Chimeras to Target Lck in T-Cell Acute Lymphoblastic Leukemia
    Hu, Jianzhong
    Jarusiewicz, Jamie
    Min, Jaeki
    Yang, Lei
    Chepyala, Divyabharathi
    Actis, Marisa
    Rowland, Lauren
    Du, Guoqing
    Smart, Brandon
    Maxwell, Dylan
    Xie, Boer
    Yoshimura, Satoshi
    Peng, Junmin
    Teachey, David
    Rankovic, Zoran
    Yang, Jun J.
    BLOOD, 2021, 138
  • [3] Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia
    Laukkanen, Saara
    Veloso, Alexandra
    Yan, Chuan
    Oksa, Laura
    Alpert, Eric J.
    Do, Daniel
    Hyvarinen, Noora
    McCarthy, Karin
    Adhikari, Abhinav
    Yang, Qiqi
    Iyer, Sowmya
    Garcia, Sara P.
    Pello, Annukka
    Ruokoranta, Tanja
    Moisio, Sanni
    Adhikari, Sadiksha
    Yoder, Jeffrey A.
    Gallagher, Kayleigh
    Whelton, Lauren
    Allen, James R.
    Jin, Alex H.
    Loontiens, Siebe
    Heinaniemi, Merja
    Kelliher, Michelle
    Heckman, Caroline A.
    Lohi, Olli
    Langenau, David M.
    BLOOD, 2022, 140 (17) : 1891 - 1906
  • [4] Preclinical evaluation of proteolytic targeting of LCK as a therapeutic approach in T cell acute lymphoblastic leukemia
    Hu, Jianzhong
    Jarusiewicz, Jamie
    Du, Guoqing
    Nishiguchi, Gisele
    Yoshimura, Satoshi
    Panetta, John C.
    Li, Zhenhua
    Min, Jaeki
    Yang, Lei
    Chepyala, Divyabharathi
    Actis, Marisa
    Reyes, Noemi
    Smart, Brandon
    Pui, Ching-Hon
    Teachey, David T.
    Rankovic, Zoran
    Yang, Jun J.
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (659)
  • [5] THERAPEUTIC POTENTIAL OF TARGETING SPHINGOSINE KINASES IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Evangelisti, Cecilia
    ANTICANCER RESEARCH, 2014, 34 (10) : 5898 - 5899
  • [6] Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review)
    Evangelisti, Camilla
    Evangelisti, Cecilia
    Chiarini, Francesca
    Lonetti, Annalisa
    Buontempo, Francesca
    Bressanin, Daniela
    Cappellini, Alessandra
    Orsini, Ester
    McCubrey, James A.
    Martelli, Alberto M.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (03) : 909 - 918
  • [7] An Update on Clinical Trials and Potential Therapeutic Strategies in T-Cell Acute Lymphoblastic Leukemia
    Patel, Janisha
    Gao, Xueliang
    Wang, Haizhen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [8] Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia
    Serafin, Valentina
    Capuzzo, Giorgia
    Milani, Gloria
    Minuzzo, Sonia Anna
    Pinazza, Marica
    Bortolozzi, Roberta
    Bresolin, Silvia
    Porcu, Elena
    Frasson, Chiara
    Indraccolo, Stefano
    Basso, Giuseppe
    Accordi, Benedetta
    BLOOD, 2017, 130 (25) : 2750 - 2761
  • [9] T-cell acute lymphoblastic leukemia
    Raetz, Elizabeth A.
    Teachey, David T.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 580 - 588
  • [10] T-cell acute lymphoblastic leukemia
    Chiaretti, Sabina
    Foa, Robin
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (02): : 160 - 162